SEARCH:   Advanced

Blood, 1 March 2006, Vol. 107, No. 5, pp. 2170-2179. Prepublished online as a Blood First Edition Paper on November 17, 2005; DOI 10.1182/blood-2005-09-3585. This Article Full Text Full Text (PDF) Supplemental Table All Versions of this Article: 2005-09-3585v1 107/5/2170    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kamminga, L. M. Articles by de Haan, G. Search for Related Content PubMed PubMed Citation Articles by Kamminga, L. M. Articles by de Haan, G. Related Collections Hematopoiesis and Stem Cells Stem Cells in Hematology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  STEM CELLS IN HEMATOLOGY The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion Leonie M. Kamminga, Leonid V. Bystrykh, Aletta de Boer, Sita Houwer, José Douma, Ellen Weersing, Bert Dontje, and Gerald de Haan From the Department of Cell Biology, Section Stem Cell Biology, University Medical Center Groningen, University of Groningen, The Netherlands. The molecular mechanism responsible for a decline of stem cell functioning after replicative stress remains unknown. We used mouse embryonic fibroblasts (MEFs) and hematopoietic stem cells (HSCs) to identify genes involved in the process of cellular aging. In proliferating and senescent MEFs one of the most differentially expressed transcripts was Enhancer of zeste homolog 2 (Ezh2), a Polycomb group protein (PcG) involved in histone methylation and deacetylation. Retroviral overexpression of Ezh2 in MEFs resulted in bypassing of the senescence program. More importantly, whereas normal HSCs were rapidly exhausted after serial transplantations, overexpression of Ezh2 completely conserved long-term repopulating potential. Animals that were reconstituted with 3 times serially transplanted control bone marrow cells all died due to hematopoietic failure. In contrast, similarly transplanted Ezh2-overexpressing stem cells restored stem cell quality to normal levels. In a "genetic genomics" screen, we identified novel putative Ezh2 target or partner stem cell genes that are associated with chromatin modification. Our data suggest that stabilization of the chromatin structure preserves HSC potential after replicative stress. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: H. Xu, S. Eleswarapu, H. Geiger, K. Szczur, D. Daria, Y. Zheng, J. Settleman, E. F. Srour, D. A. Williams, and M.-D. Filippi Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential Blood, October 22, 2009; 114(17): 3557 - 3566. [Abstract] [Full Text] [PDF] A. G. Muntean and J. L. Hess Epigenetic Dysregulation in Cancer Am. J. Pathol., October 1, 2009; 175(4): 1353 - 1361. [Abstract] [Full Text] [PDF] W. Fiskus, Y. Wang, A. Sreekumar, K. M. Buckley, H. Shi, A. Jillella, C. Ustun, R. Rao, P. Fernandez, J. Chen, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells Blood, September 24, 2009; 114(13): 2733 - 2743. [Abstract] [Full Text] [PDF] D. G. Kent, M. R. Copley, C. Benz, S. Wohrer, B. J. Dykstra, E. Ma, J. Cheyne, Y. Zhao, M. B. Bowie, Y. Zhao, et al. Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential Blood, June 18, 2009; 113(25): 6342 - 6350. [Abstract] [Full Text] [PDF] H. Chen, X. Gu, I-h. Su, R. Bottino, J. L. Contreras, A. Tarakhovsky, and S. K. Kim Polycomb protein Ezh2 regulates pancreatic {beta}-cell Ink4a/Arf expression and regeneration in diabetes mellitus Genes & Dev., April 15, 2009; 23(8): 975 - 985. [Abstract] [Full Text] [PDF] G. H. S. Richter, S. Plehm, A. Fasan, S. Rossler, R. Unland, I. M. Bennani-Baiti, M. Hotfilder, D. Lowel, I. von Luettichau, I. Mossbrugger, et al. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation PNAS, March 31, 2009; 106(13): 5324 - 5329. [Abstract] [Full Text] [PDF] A. Tzatsos, R. Pfau, S. C. Kampranis, and P. N. Tsichlis Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus PNAS, February 24, 2009; 106(8): 2641 - 2646. [Abstract] [Full Text] [PDF] D. G. Kent, B. J. Dykstra, J. Cheyne, E. Ma, and C. J. Eaves Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells Blood, August 1, 2008; 112(3): 560 - 567. [Abstract] [Full Text] [PDF] M. Zhang, F. Behbod, R. L. Atkinson, M. D. Landis, F. Kittrell, D. Edwards, D. Medina, A. Tsimelzon, S. Hilsenbeck, J. E. Green, et al. Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer Cancer Res., June 15, 2008; 68(12): 4674 - 4682. [Abstract] [Full Text] [PDF] N. Riggi, M.-L. Suva, D. Suva, L. Cironi, P. Provero, S. Tercier, J.-M. Joseph, J.-C. Stehle, K. Baumer, V. Kindler, et al. EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells Cancer Res., April 1, 2008; 68(7): 2176 - 2185. [Abstract] [Full Text] [PDF] D. Kent, M. Copley, C. Benz, B. Dykstra, M. Bowie, and C. Eaves Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway Clin. Cancer Res., April 1, 2008; 14(7): 1926 - 1930. [Abstract] [Full Text] [PDF] A. Rizo, B. Dontje, E. Vellenga, G. de Haan, and J. J. Schuringa Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1 Blood, March 1, 2008; 111(5): 2621 - 2630. [Abstract] [Full Text] [PDF] J. Tan, X. Yang, L. Zhuang, X. Jiang, W. Chen, P. L. Lee, R.K. M. Karuturi, P. B. O. Tan, E. T. Liu, and Q. Yu Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells Genes & Dev., May 1, 2007; 21(9): 1050 - 1063. [Abstract] [Full Text] [PDF] J. Z. Maines, J. K. Park, M. Williams, and D. M. McKearin Stonewalling Drosophila stem cell differentiation by epigenetic controls Development, April 15, 2007; 134(8): 1471 - 1479. [Abstract] [Full Text] [PDF] A. P. Bracken, D. Kleine-Kohlbrecher, N. Dietrich, D. Pasini, G. Gargiulo, C. Beekman, K. Theilgaard-Monch, S. Minucci, B. T. Porse, J.-C. Marine, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells Genes & Dev., March 1, 2007; 21(5): 525 - 530. [Abstract] [Full Text] [PDF] W. Fiskus, M. Pranpat, M. Balasis, B. Herger, R. Rao, A. Chinnaiyan, P. Atadja, and K. Bhalla Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells Mol. Cancer Ther., December 1, 2006; 5(12): 3096 - 3104. [Abstract] [Full Text] [PDF] A. Rizo, E. Vellenga, G. de Haan, and J. J. Schuringa Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R210 - R219. [Abstract] [Full Text] [PDF]

	Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020